The interaction of de novo and pre-existing aortic regurgitation after TAVI: insights from a new quantitative aortographic technique

Hiroki Tateishi(Erasmus University Rotterdam), Fabio de Brito, Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway), Yosuke Miyazaki(Yamaguchi University), Alexandre Abizaid(Universidade de São Paulo), Carlos M. Campos(Universidade de São Paulo), Tristan Slots, Pedro A. Lemos(Johns Hopkins University), Carlos Collet(Onze Lieve Vrouwziekenhuis Hospital), Ernest Spitzer(Erasmus MC), José Armando Mangione, Osama Soliman(Health Service Executive), Rafael Cavalcante(Erasmus MC), Patrick W. Serruys(St. Luke's Hospital), Rogério Sarmento Leite(Fundação Universitária de Cardiologia), Mohammad Abdelghani(Amsterdam UMC Location University of Amsterdam)
EuroIntervention
May 1, 2017
10.4244/eij-d-16-00647
Cited by 16

Related Papers

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
|Circulation|2018|926
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II
|The Lancet|2013|827
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
|New England Journal of Medicine|2021|571
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI
|Journal of the American College of Cardiology|2016|438